Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

CRISPR Therapeutics raises more money

Country: Switzerland

As gene editing technologies gain more traction, companies producing the new technologies are attracting more money from investors. One such company is CRISPR Therapeutics of Switzerland that has a number of preclinical projects investigating gene editing for therapeutic use.

Read more

Merck to acquire Afferent

Country: United States

Merck & Co Inc has announced plans to acquire privately-held Afferent Pharmaceuticals of San Mateo, California, US for up to $1.25 billion depending on the achievement of specific clinical and commercial milestones.

Read more

Jazz Pharmaceuticals to buy Celator

Country: Ireland

Read more

Funding for Freeline Therapeutics

Country: United Kingdom

Read more

Pfizer completes Anacor acquisition

Country: United States

Read more

Green light for MolMed cell therapy

Country: Italy

Read more

CRISPR raises more money

Country: Switzerland

Read more

Discovery of apoptosis antibody reported

Country: Australia

Read more

Role of TP53 described

Country: Belgium

Read more

‘Writing’ the human genome

Country: United States

Read more

New link between Alzheimer’s and diabetes?

Country: United Kingdom

Read more

Vernona Pharma to raise £44.7 million

Country: United Kingdom

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

Why industry is investing in bispecific molecules

BisoecificApproach (1).pdf

Highlights of the May 2016 MedNous issue

The May 2016 MedNous features:

Latest Mednous cover
  • Oncology Development
    The bispecific approach attracts more followers
  • Drug Development
    European biotechs succeed without partners
    By Robin Davison
  • Commentary
    Good deals getting harder for Pharma
    By Martin Gouldstone
  • Regenerative Medicine
    Oxford startup attracts scientific elite
  • Company News
    Argenx lures AbbVie with preclinical antibody

The latest MedNous journal. Subscribe to download.

Recent Appointments